ANTI-NUTRITIONAL CONSTITUENT OF COLOCASIA ESCULENTA ...
ANTI-NUTRITIONAL CONSTITUENT OF COLOCASIA ESCULENTA ... ANTI-NUTRITIONAL CONSTITUENT OF COLOCASIA ESCULENTA ...
diabetes mellitus or obesity. Octivio and Rigden (2000) referred to a-amylase and its inhibitors as 'drug-design targets' from which compounds for the treatment of diabetes, obesity and hyperlipaemia could be developed. Btl.3 Aim and outline ofSection B-1 Amylase inlnbitors have been extracted from several types of plants, especially those in the cereal and legume family. In contrast to a-amylase inhibitors in cereal (Roy and Gupta, 2000; Heidari et al., 2005; Muralikrishna and Nirma1a, 2005) and legumes (Giri and Kachole, 1998; Melo et ai, 1999), which have been extensively studied, little is known about the structural features and properties oftuber a-amylase inhibitors. The aim of Section B-1 was therefore to extract, isolate and characterize a-amylase inhibitors from Amadumbe. The objectives were: • the extraction, isolation and partial purification ofa-amylase inhibitors through ion-exchange and gel chromatography; • to undertake kinetic studies (pH and temperature optima); and • to investigate the selectivity ofinhibitor action on different a-amylases. 124
B1.2.1 Introduction B1.2.2 Materials B1.23 Methods CHAPTER BI-2 MATERIALS AND METHODS This chapter gives a brief description of the materials and methods used to isolate, partially purify and characterize a-amylase inhibitors from white Colocasia esculenta grown in Esikhawini, Zululand, South Africa. (See Appendices A and B for details). The white variety of Amadumbe (Colocasia esculenta) tubers was obtained from the local maIket in Esikhawini, Kwazulu-Nata1, South-Africa. Commercially available amylases (human saliva, type IX-A; porcine pancreatic, type I-A; sweet potato, barley, Bacillus species, type IT-A; Aspergillus oryzae) and all other reagents used were obtained from Sigma Chemical Company. (See Appendix B for details ofmethodology.) 125
- Page 91 and 92: TIA indicated that the trypsin inhi
- Page 93 and 94: samples in this study were also hig
- Page 95 and 96: The cyanogen levels for Amadumbe tu
- Page 97 and 98: CHAPTERA-5 CONCLUSION A.5.1 Nutriti
- Page 99 and 100: In conclusion, Section A ofthis stu
- Page 101 and 102: Alfaia S., Ribeiro G., Nobre A, Lui
- Page 103 and 104: Bhattacharyya A, Rai S. and Babu CR
- Page 105 and 106: Chavan U.D., Shahidi F. and Naczk M
- Page 107 and 108: De la Cuadra C., Muzquiz M, Burbano
- Page 109 and 110: Fatty acids. (2008) CyberlipidCente
- Page 111 and 112: Grant G. (1991) Lectins. In: Toxic
- Page 113 and 114: HofmanP., Vuthapanich S., Whiley A,
- Page 115: Jobnson LT., Gee J.M, Price K.R., C
- Page 118 and 119: MagaJA (1978) Simple phenols and ph
- Page 120 and 121: Milton K. (2003) Micronutrient inta
- Page 122 and 123: Noonan S.C. and Savage G.P. (1999)
- Page 124 and 125: Pathirana C, Gibney MJ. and Taylor
- Page 126 and 127: Quesada C., Bartolome B., Nieto 0.,
- Page 128 and 129: Robertson RN., Highkin H.R., Smydzu
- Page 130 and 131: Sheeba R. and Padmaja G. (1997) Mec
- Page 132 and 133: Thompson L.U. (1988) Antinutrients
- Page 134 and 135: Vijayakumari K, Siddhuraju P. and J
- Page 136 and 137: PURIFICATION AND AMYLASE INHIBITOR
- Page 138 and 139: calcium metalloenzymes, are complet
- Page 140 and 141: Bl.1.2.4 Kunitz-Iike a-amylase inhi
- Page 144 and 145: B1.2.3.1 Extraction and purificatio
- Page 147: BI.3.1 BI.3.2.1 Introduction CHAPTE
- Page 152: B1.3.2.2 Kinetic studies The inhibi
- Page 155 and 156: Bl.4.1 B1.4.2 Introduction CHAPTER
- Page 157 and 158: Bl.4.3.3 results that amylase inhib
- Page 159 and 160: The chemical structure ofits sapoge
- Page 162 and 163: 12.1.2.3 Steroidal saponin The trit
- Page 164 and 165: (the in vitro haemolytic activity)
- Page 167 and 168: 82.2.3.2 82.2.3.2.1 B2.2.3.2.2 Air-
- Page 169 and 170: 82.2.3.3.4 • ion source temperatu
- Page 173: Figure 82-3.3: Chromatogram ofsapon
- Page 180 and 181: Gamma- and possibly beta-sitosterol
- Page 182: whereas beta-sitosterol was. It was
- Page 185 and 186: Cheeke PR. (1971) Nutritional and p
- Page 187 and 188: Franco O.L., Rigden D.L., Melo F.R
- Page 190 and 191: Kokiladevi E., Manickam A and Thayu
B1.2.1 Introduction<br />
B1.2.2 Materials<br />
B1.23 Methods<br />
CHAPTER BI-2<br />
MATERIALS AND METHODS<br />
This chapter gives a brief description of the materials and methods used to isolate,<br />
partially purify and characterize a-amylase inhibitors from white Colocasia esculenta<br />
grown in Esikhawini, Zululand, South Africa. (See Appendices A and B for details).<br />
The white variety of Amadumbe (Colocasia esculenta) tubers was obtained from the<br />
local maIket in Esikhawini, Kwazulu-Nata1, South-Africa. Commercially available<br />
amylases (human saliva, type IX-A; porcine pancreatic, type I-A; sweet potato, barley,<br />
Bacillus species, type IT-A; Aspergillus oryzae) and all other reagents used were obtained<br />
from Sigma Chemical Company.<br />
(See Appendix B for details ofmethodology.)<br />
125